Back to Resources

To lower costs, enhance efficiency, increase flexibility and improve data quality while ensuring patient access to new treatments, the drug development industry is pursuing new approaches to clinical trial design. SCORR Marketing and Applied Clinical Trials surveyed professionals in the health science industry to understand the nature and effectiveness of these emerging study designs.

In this report, we compiled information on:

  • What types of companies are most likely to have a department or team dedicated to innovative clinical trial design
  • Most common emerging trial designs
  • Two-year outlook for innovative trial designs
  • How these approaches are implemented
  • Benefits realized by adopting innovative study designs
  • Which kinds of trials offer the best ROI
  • How well these approaches have met operational and financial objectives